急诊科医生与高级护理提供者治疗急性胸痛时阿片类药物使用比较
本研究为回顾性研究,纳入2021年1月至2024年1月在某学术急诊科就诊的成人ACS患者2055例,其中154例(7.5%)由高级护理提供者(ACP)治疗,1901例(92.5%)由医生治疗。主要结局为静脉吗啡给药,次要结局为静脉芬太尼给药。结果显示,两组吗啡使用率相似(42.2% vs 42.8%,p=0.93),ACP组芬太尼使用较少(5.8% vs 11.6%,p=0.03)。多变量logistic回归调整人口学、临床因素及阿片前硝酸甘油给药后,ACP与医生身份与吗啡(OR 0.78,95%CI 0.49-1.24)或芬太尼(OR 1.10,95%CI 0.50-2.49)使用无显著关联。阿片前硝酸甘油给药与阿片类药物给药减少强烈相关。敏感性分析证实上述发现。
要点
- 在2055例ACS相关胸痛成人患者中,ACP组与医生组吗啡使用率相似(42.2% vs 42.8%,p=0.93)。
- ACP组芬太尼使用率低于医生组(5.8% vs 11.6%,p=0.03),但调整后无显著差异(OR 1.10,95%CI 0.50-2.49)。
- 调整后ACP与医生身份与吗啡使用无显著关联(OR 0.78,95%CI 0.49-1.24)。
- 阿片前硝酸甘油给药与阿片类药物给药减少强烈相关。
- 敏感性分析(Firth惩罚logistic回归)证实主要发现。
适用人群与场景
- 2021年1月至2024年1月在某学术急诊科就诊的成人ACS患者,共2055例。
- 其中154例(7.5%)由高级护理提供者(ACP)治疗,1901例(92.5%)由医生治疗。
处置流程与药物剂量
- 当硝酸酯类治疗后症状持续时使用阿片类药物如吗啡和芬太尼。
- 研究比较了静脉吗啡和静脉芬太尼的处方模式,但未给出具体剂量方案。
研究设计与关键结果
- 研究类型:回顾性研究;样本量2055例;人群:成人ACS患者;干预与对照:ACP治疗 vs 医生治疗。
- 主要终点:静脉吗啡给药率ACP组42.2% vs 医生组42.8%(p=0.93),无显著差异。
- 次要终点:静脉芬太尼给药率ACP组5.8% vs 医生组11.6%(p=0.03)。
- 调整后ACP vs 医生身份与吗啡使用无显著关联(OR 0.78,95%CI 0.49-1.24),与芬太尼使用无显著关联(OR 1.10,95%CI 0.50-2.49)。
- 阿片前硝酸甘油给药与阿片类药物给药减少强烈相关;敏感性分析证实这些发现。
证据类型、等级与局限
- 证据类型:回顾性研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在学术急诊科中,ACP与医生对ACS相关胸痛的阿片类药物处方决策 after adjustment 无显著差异,处方更多由患者因素和治疗顺序驱动。
- 阿片前硝酸甘油给药与阿片类药物给药减少强烈相关,提示治疗顺序可能影响阿片使用。
- 作者认为,这些发现支持ACP与医生在急诊ACS疼痛管理中具有可比角色。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute chest pain is a common and high-stakes emergency department (ED) presentation, frequently associated with acute coronary syndrome (ACS). Opioids such as morphine and fentanyl are used when symptoms persist despite nitrates, but little is known about whether prescribing differs between advanced care providers (ACPs) and physicians.
OBJECTIVE: To compare intravenous (IV) morphine and fentanyl prescribing patterns for ACS-related chest pain between ACPs and physicians in an academic ED.
METHODS: We performed a retrospective study of adult patients with ACS presenting to an academic ED from January 2021 to January 2024. The primary outcome was IV morphine administration; the secondary outcome was IV fentanyl administration. Multivariable logistic regression adjusted for demographics, clinical factors, and nitroglycerin administration prior to opioid. Firth's penalized logistic regression was conducted as sensitivity analysis.
RESULTS: Among 2055 patients, 154 (7.5 %) were treated by ACPs and 1901 (92.5 %) by physicians. Morphine use was similar between groups (42.2 % vs 42.8 %, p = 0.93), while fentanyl was less common with ACPs (5.8 % vs 11.6 %, p = 0.03). In adjusted models, ACP vs Physician status was not significantly associated with morphine (OR 0.78, 95 % CI 0.49-1.24) or fentanyl use (OR 1.10, 95 % CI 0.50-2.49). Nitroglycerin prior to opioid was strongly associated with reduced opioid administration. Sensitivity analyses confirmed these findings.
CONCLUSION: Opioid prescribing for ACS-related chest pain did not differ significantly between ACPs and physicians after adjustment. Prescribing decisions were driven more by patient factors and treatment sequencing, supporting comparable roles for ACPs and physicians in ED ACS pain management.
参考来源
- Laughter C, Alsayyed A, Shubair M, et al. Comparing physician and advanced care provider use of opioids for treatment of acute chest pain in the emergency department. Am J Emerg Med. 2025. PMID: 41004927. doi:10.1016/j.ajem.2025.09.037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。